Product image of Eltrombopag Cipla (Eltrombopag) supplied by GNH India

Eltrombopag Cipla

Active Ingredient:
Eltrombopag
Origin:
EU

Eltrombopag Cipla (Eltrombopag)

Eltrombopag Cipla is a medication used to stimulate platelet production. It is commonly prescribed for conditions affecting blood cell counts, such as certain types of anemia or low platelet levels. This oral medication is manufactured by Cipla Europe NV.

Manufacturer / TM Owner

Cipla Europe Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Eltrombopag Cipla is primarily used to increase platelet counts in individuals with specific blood disorders. It is often prescribed for conditions where the body does not produce enough platelets, which can lead to bleeding or bruising. This medication works by stimulating the bone marrow to produce more platelets, helping to maintain healthy blood cell levels.

Side Effects

  • Common effects of Eltrombopag Cipla may include headaches, nausea, and fatigue. Some individuals might experience dizziness or stomach discomfort. These effects vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

  • Eltrombopag Cipla should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies.

Avoid Interactions

  • Eltrombopag Cipla can interact with other medications, including certain antibiotics and antifungals. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how this medication works.

Frequently Asked Questions

Eltrombopag Cipla is used to stimulate platelet production in individuals with certain blood disorders.

Eltrombopag Cipla is taken orally, typically once daily. Follow the specific instructions provided by your healthcare professional.

Common side effects may include headaches, nausea, fatigue, and dizziness.

Eltrombopag Cipla can interact with other medications, so it is important to consult a healthcare professional before combining it with other treatments.

Individuals with certain medical conditions or allergies should avoid taking Eltrombopag Cipla unless advised otherwise by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eltrombopag

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT